Menu Latest News Affordable UHC Reproductive, Maternal, Newborn and Child Health Infectious Diseases Noncommunicable Diseases Service Capacity and Access Biomedical Technology Global Contributions Safeguarding Global Health Combating Major Diseases Building Medical Capacity Humanitarian Medical Aid Front-line Experiences
National Health Research Institutes and Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceuticals Company Limited, join forces in the area of genome research to develop rare disease drugs
CRISPR/Cas9: A revolutionary genomic engineering strategy in treating inherited hematopoietic disorders
Psychological stress triggers physical pain–Probing pathophysiology of fibromyalgia with translational research
Biomedicine Combining with Semiconductor to Precisely Treat Parkinson’s Disease - The Development of Prospective Miniature System-on-a-Chip